Award
National Cancer Institute 3R01CA261937-05S1
Functional and Therapeutic Significance of PLK4 in Melanoma
Recipient
National Cancer Institute (NCI), part of the NIH, United States
Award Amount
$82,457.00
Ceiling
$82,457.00
Awarded
July 28, 2026
Identifier
3R01CA261937-05S1
Research project awarded by NIH/NCI to study the role of PLK4 in melanoma, including therapeutic targeting and mechanistic studies.
Description
This is a research project funded by the NIH/NCI focusing on the role of PLK4 in melanoma. The project involves in vivo and ex vivo studies, with a focus on therapeutic targeting and mechanistic understanding.